Pedro Rafael Vieira de Oliveira Salerno

Mr. Pedro Rafael Vieira de Oliveira Salerno

Faculdade pernambucana de saúde, Recife, Pernambuco, Brazil
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2023 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Closed access
IMIssam Motairek
Issam Motairek
ZCZhuo Chen
Zhuo Chen
MMMohamed Hegazy Elshahat Makhlouf
Mohamed Hegazy Elshahat Makhlouf
SDSalil Deo
Salil Deo
Pedro Rafael Vieira de Oliveira SalernoPedro Rafael Vieira de Oliveira Salerno
Pedro Rafael Vieira de Oliveira Salerno
SASadeer G. Al-Kindi
Sadeer G. Al-Kindi

28 March 2024 in Medicina
Verified
Journal Article
Open access
PDF file
NHNeda Shafiabadi Hassani
Neda Shafiabadi Hassani
LOLucas Carlini Ogliari
Lucas Carlini Ogliari
Pedro Rafael Vieira de Oliveira SalernoPedro Rafael Vieira de Oliveira Salerno
Pedro Rafael Vieira de Oliveira Salerno
GPGabriel Tensol Rodrigues Pereira
Gabriel Tensol Rodrigues Pereira
MRMarcelo Harada Ribeiro
Marcelo Harada Ribeiro
Luis Augusto Palma DallanLuis Augusto Palma Dallan
Luis Augusto Palma Dallan
Despite ongoing progress in stent technology and deployment techniques, in-stent restenosis (ISR) still remains a major issue following percutaneous coronary intervention (PCI) and accounts for 10.6% of all interventions in the United States. With the continuous rise in ISR risk factors such as obesity and diabetes, along with an increase in the treatment of complex lesions with high-risk percutaneous coronary intervention (CHIP), a substantial growth in ISR burden is expected. This review aims to provide insight into the mechanisms, classification, and management of ISR, with a focus on exploring innovative approaches to tackle this complication comprehensively, along with a special section addressing the approach to complex calcified lesions.

3 October 2023 in Public Health
Verified
Journal Article
Closed access
Pedro Rafael Vieira de Oliveira SalernoPedro Rafael Vieira de Oliveira Salerno
Pedro Rafael Vieira de Oliveira Salerno
CBCamilo Briones-Valdivieso
Camilo Briones-Valdivieso
IMI. Motairek
I. Motairek
Luis Augusto Palma DallanLuis Augusto Palma Dallan
Luis Augusto Palma Dallan
SRS. Rajagopalan
S. Rajagopalan
SAS. Al-Kindi
S. Al-Kindi

20 August 2024 in Public Health
Verified
Journal Article
Closed access
CBCamilo Briones-Valdivieso
Camilo Briones-Valdivieso
Pedro Rafael Vieira de Oliveira SalernoPedro Rafael Vieira de Oliveira Salerno
Pedro Rafael Vieira de Oliveira Salerno
Eva Maria Navarrete-MuñozEva Maria Navarrete-Muñoz
Eva Maria Navarrete-Muñoz
Desirée Valera-GranDesirée Valera-Gran
Desirée Valera-Gran
Rubén López-BuenoRubén López-Bueno
Rubén López-Bueno
Fanny Petermann-RochaFanny Petermann-Rocha
Fanny Petermann-Rocha

21 October 2024 in JACC
Verified
Journal Article
Closed access
ZCZhuo Chen
Zhuo Chen
Pedro Rafael Vieira de Oliveira SalernoPedro Rafael Vieira de Oliveira Salerno
Pedro Rafael Vieira de Oliveira Salerno
JDJean-Eudes Dazard
Jean-Eudes Dazard
SSSantosh Kumar Sirasapalli
Santosh Kumar Sirasapalli
MMMohamed H.E. Makhlouf
Mohamed H.E. Makhlouf
SRsanjay Rajagopalan
sanjay Rajagopalan

3 June 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
Pedro Rafael Vieira de Oliveira SalernoPedro Rafael Vieira de Oliveira Salerno
Pedro Rafael Vieira de Oliveira Salerno
PLP. Grace Tee Lewis
P. Grace Tee Lewis
ZCZhuo Chen
Zhuo Chen
JDJean‐Eudes Dazard
Jean‐Eudes Dazard
SGSarju Ganatra
Sarju Ganatra
SASadeer Al‐Kindi
Sadeer Al‐Kindi
Background: There is an incomplete understanding of the impact of climate change on cardiovascular‐kidney‐metabolic (CKM) syndrome. Although climate change affects all Americans, certain communities and individuals may suffer a disproportionate burden. Therefore, this study's objective was to explore the relationship between the Climate Vulnerability Index domains and the prevalence of CKM components in the United States. Methods: This cross‐sectional study obtained health outcomes from Centers for Disease Control and Prevention Population Level Analysis and Community Estimates (2021) and assessed the census tract‐level prevalence of coronary heart disease, chronic kidney disease, obesity, diabetes, dyslipidemia, and hypertension. ANOVA was used to assess statistically significant differences in the means of CKM components between quartiles of each climate change domain. Linear regression models assessed the association between each domain and outcome, followed by models adjusted by baseline Climate Vulnerability Index components. Fully adjusted models included all 3 climate change domains and the baseline Climate Vulnerability Index components. Results: Data for 70 300 census tracts, covering 299.8 million individuals, were included. Statistically significant differences ( P <0.001) in CKM prevalence were found between quartiles of all climate change domains. These associations persisted after adjusting for baseline domains (environment, social/economic, and infrastructure) and in the full model including all domains. Conclusions: The Climate Vulnerability Index's climate change component was associated with the prevalence of CKM components (coronary heart disease, chronic kidney disease, obesity, diabetes, dyslipidemia, and hypertension). These findings suggest that populations with CKM may be associated with increased climate vulnerability, underscoring the need for a deeper understanding of climate change as a determinant of health.